Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Chronic respiratory diseases are the third leading cause of death, behind cardiovascular diseases and cancer, affecting approximately 550 million of people all over the world. Most of the chronic respiratory diseases are attributable to asthma and chronic obstructive pulmonary disease (COPD) with th...
Guardado en:
Autores principales: | Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, Alberto Papi, Aida Emirova, Mirco Govoni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/622a70fbc2e348a4a103a94d0a8020b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Phosphodiesterase-4 Inhibition in Psoriasis
por: Milakovic M, et al.
Publicado: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
por: Priyadarshini Kachroo, et al.
Publicado: (2021) -
The Involvement of PDE4 in the Protective Effects of Melatonin on Cigarette-Smoke-Induced Chronic Obstructive Pulmonary Disease
por: Je-Oh Lim, et al.
Publicado: (2021) -
Lung Health in the Solomon Islands: A Mixed Methods Study
por: Di Michiel J, et al.
Publicado: (2021) -
The Role of PDE11A4 in Social Isolation-Induced Changes in Intracellular Signaling and Neuroinflammation
por: Katy Pilarzyk, et al.
Publicado: (2021)